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a  b  s  t  r  a  c  t
Long  non-coding  RNAs  (lncRNAs)  are  emerging  as  an  important  class  of regulatory  transcripts  that
are  implicated  in  a  variety  of  biological  functions.  RNA-sequencing,  along  with  other  next-generationeywords:
ext-generation sequencing
NA-seq
on-coding RNA
ntisense transcript
sequencing-based  approaches,  enables  their  study  on  a genome-wide  scale,  at maximal  resolution,  and
across multiple  conditions.  This  review  discusses  how  sequencing-based  studies  are  providing  global
insights  into  lncRNA  transcription,  post-transcriptional  processing,  expression  regulation  and  sites  of
function.  The  next  few  years  will  deepen  our  insight  into  the  overall  contribution  of lncRNAs  to  genome
function  and  to  the  information  ﬂow  from  genotype  to phenotype.
 ene regulation © 2011 Elsevier Ltd. 
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. Introduction approaches, RNA-seq does not depend on available genome anno-
tation or sequence, can accurately detect expression levels over
Open access under CC BY-NC-ND license.RNA-sequencing (RNA-seq), based on next-generation (NGS)
equencing of cDNAs, is transforming the characterisation
nd quantiﬁcation of transcriptomes. Unlike microarray-based
Abbreviations: AS, antisense; ncRNAs, non-coding RNAs; ChIP-seq, chro-
atin immunoprecipation with sequencing; CAR, chromatin-associated ncRNA;
UT, cryptic unstable transcript; eRNAs, enhancer RNAs; GRO-seq, global run-on
equencing; GWAS, genome-wide association studies; lincRNAs, long intergenic
cRNAs; lncRNAs, long non-coding RNAs; NET-seq, native elongating transcript
equencing; NGS, next-generation-sequencing; Pol II, RNA polymerase II; RNA-seq,
NA sequencing; SUT, stable unannotated transcript.
∗ Corresponding author. Tel.: +44 0203 108 1602; fax: +44 0207 679 7096.
E-mail address: j.bahler@ucl.ac.uk (J. Bähler).
084-9521 © 2011 Elsevier Ltd. 
oi:10.1016/j.semcdb.2011.12.003
Open access under CC BY-NC-ND license. a wide dynamic range, and can reveal entire transcriptomes with
high sensitivity and to nucleotide resolution (reviewed in [1–3]).
A profusion of microarray and RNA-seq studies, on species ranging
from simple microbes to humans, has revealed that the transcribed
portions of genomes are much more pervasive and more complex
than anticipated [4–8]. For example, less than 2% of the human
genome encodes for proteins, yet as much as 80% of all DNA is
transcribed [9,10].
Such pervasive transcription leads to a multitude of previ-
ously unknown non-coding RNAs (ncRNAs), many of which have
an arbitrary minimal length cut-off of 200 nucleotides (due to
RNA-seq library preparation protocols that exclude small RNAs),
and are subsequently referred to as long ncRNAs (lncRNAs). These
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Fig. 2. Different types of long non-coding RNAs. Scheme showing different cate-
gories of transcripts. Green: DNA, with promoters and open reading frames (ORFs)
depicted as boxes; blue arrows: messenger RNAs (mRNAs); red arrows: lncRNAs.
Examples for different lncRNAs are antisense (AS) RNAs, promoter RNAs transcribedig. 1. Research on long non-coding RNAs is rapidly increasing. Cumulative plot of
he total number of publication entries in PubMed (blue line and axis) and of entries
elated to long non-coding RNAs (red line and axis).
ranscripts are distinct from small regulatory ncRNAs such as siR-
As, miRNAs and piRNAs, which are typically conserved, shorter
han 30 nucleotides, and are involved in transcriptional and post-
ranscriptional gene silencing through speciﬁc base-pairing with
heir mRNA targets (reviewed in [11]). lncRNAs tend to be lowly
xpressed [7,12,13] and, although they are less conserved than
rotein-coding genes, there is evidence that they have been subject
o purifying selection, hinting at their possible functionality [14,15].
oreover, the evolutionary rates and expression levels of lncRNAs
re anti-correlated, a characteristic they share with protein-coding
enes [16]. While protein-coding genes are largely conserved in
umber and function between organisms of highly different com-
lexities [10], the extent of lncRNAs increases much more with
rganismal complexity. Differences in genome regulation, possi-
ly mediated to a substantial degree by lncRNAs, may  contribute
igniﬁcantly to phenotypic differences between and within species
reviewed in [10]).
Determining the nature and possible biological functions of
ncRNAs has been a rapidly developing ﬁeld over the past decade
Fig. 1). The ﬁeld has been pioneered by mechanistic studies of sin-
le genes, which have unravelled a variety of functions of lncRNAs
n gene regulation (reviewed in [17,18]). Today, with its unrivalled
ensitivity and resolution, RNA-seq allows the detection and quan-
iﬁcation of lncRNAs on a genome-wide scale, revealing the global
xtent and complexity of non-coding transcriptomes. This review
ill provide an overview of how RNA-seq and other sequencing-
ased approaches are enlightening the genomic origins, expression
egulation, and functions of lncRNAs.
. Genomic origins of lncRNA transcription
RNA-seq studies have provided a genome-wide view of where
ncRNAs are transcribed relative to coding regions. Several classes
f lncRNAs can be distinguished, which are discussed in sepa-
ate sections below: transcripts antisense to protein-coding genes,
idirectional promoter transcripts, transcripts associated with
nhancers or repetitive regions, and other transcripts originating
n intergenic regions (Fig. 2). Note that these different classes are
ot mutually exclusive, and it is not yet clear whether and how the
lassiﬁcation reﬂects biological function.in  opposite direction to mRNAs, and a long intergenic RNA (lincRNA). Some lncRNAs
are associated with enhancer elements or with repeated regions. See main text for
details.
2.1. Antisense transcripts
Standard RNA-seq libraries do not preserve information about
transcriptional direction. However, several methods now exist
for strand-speciﬁc RNA-seq (reviewed in [19]), revealing com-
plex overlapping transcription in several genomes, with many
lncRNAs being transcribed from the complementary strand of
protein-coding genes. Such lncRNAs are referred to as antisense
(AS) transcripts. Larger genomes have more complex transcrip-
tomes, and therefore require a greater sequencing depth for
adequate coverage. Given sequencing costs, simpler genomes are
more amenable to high coverage to reveal their entire transcript
repertoire. Therefore simple model organisms with smaller, more
compact genomes, such as yeasts, have been instrumental in
revealing the nature of often lowly expressed and complex AS tran-
scripts.
Initial studies using whole-genome tiling arrays in both ﬁs-
sion and budding yeast have revealed extensive AS transcription in
rapidly proliferating cells [7,20–23]. Application of strand-speciﬁc
RNA-seq to these eukaryotic microbes has now provided maps of
AS transcription across different growth conditions at the high-
est possible resolution [24–26].  Such studies provide accurate
detection of AS transcript boundaries, uncovering overlaps with
variable portions of coding genes. In addition, AS transcript co- or
anti-regulation (or lack thereof) with neighbouring genes suggest
that they can arise from novel transcription start sites, but also
from bidirectional transcription at promoters, or via transcriptional
read-through in the case of convergent genes [24–26].  Several
chromatin structure mutants also show higher prevalence of AS
transcription [27,28].  The same studies have additionally reported
that detectable AS transcripts do not originate randomly in the
genome but are more likely to overlap genes involved in sexual dif-
ferentiation or stress response [24–26],  as well as genes with higher
variability in transcript levels [23]. Notably, certain sense/AS tran-
script pairs and their co-regulation are conserved across several
yeast species [25,26]. Taken together, these data suggest that AS
transcription is a phenomenon of pervasive gene expression with
diverse features and impacts on gene regulation. For instance, in
the case of genes with highly variable gene expression, AS tran-
scripts help to tightly shut off basal transcription [23]. Microarray-
and NGS-based approaches have also revealed AS transcription in
mammalian genomes [5,9,29], but to what degree and by what
mechanisms AS transcripts control sense transcripts remains to be
fully elucidated (reviewed in [30]).
2.2. Bidirectional promoter transcription
NGS-based approaches have helped to reveal an unanticipated
property of RNA polymerase II (Pol II): transcriptional initiation
can be bi-directional. For example, the cryptic unstable transcripts
(CUTs) are Pol II-dependent transcripts deﬁned in budding yeast
can result from such bi-directional transcription. CUTs are degraded
by the nuclear exosome shortly after synthesis [31]. Two recent
studies have generated genome-wide maps of CUTs using NGS [32]
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r high-density tiling arrays [22]. Both studies have revealed that
UTs are well-deﬁned transcriptional units that tend to be tran-
cribed from gene promoters in an opposite direction to the coding
NAs. This divergent transcription from promoters is not limited to
nstable transcripts that are rapidly degraded by the nuclear exo-
ome: stable unannotated transcripts (SUTs) can also arise from
ivergent transcription from known promoters [22].
Similar transcriptional patterns have been observed in other
ukaryotes. Exosome depletion in human ﬁbroblasts followed by
iling array analysis has revealed lncRNAs which map  upstream of
nown protein-coding genes. Such promoter-upstream transcripts
ave been termed PROMPTs [33]. In addition, stable transcripts
apping to both strands of promoters are detected in meta-
oan cells. RNA-seq of short RNAs (∼20–200 nucleotides) from
ouse embryonic stem cells has shown that many of these
ranscripts originate from promoters (transcription start site-
ssociated RNAs) and are transcribed in a non-random, divergent
irection [34]. Furthermore, Core et al. [35] have employed global
un-on sequencing (GRO-seq) to identify nascent RNAs associated
ith actively transcribing Pol II in human ﬁbroblasts, indepen-
ently of nascent transcript length or stability. This analysis has
evealed that 77% of the transcriptionally active protein-coding
enes display signiﬁcant divergent transcription from promoters.
oreover, bidirectional transcripts have been reported to initiate
rom retrotransposons [36].
In summary, bidirectional transcription from promoters seems
o be a widespread phenomenon conserved across evolution. There
ave been suggestions that such bidirectional transcription may
acilitate protein-coding gene expression by promoting an open-
hromatin structure at the promoter or by recruiting positive
r negative transcriptional regulators. It is not known, however,
hether most bidirectional transcripts are non-functional by-
roducts of coding transcription, or whether they play regulatory
oles (reviewed in [37]).
.3. Enhancer associated lncRNAs
Enhancers spatially and temporally regulate protein-coding
ranscription from a distance and in an orientation-independent
anner, relative to the regulated gene. Initial studies of the -
lobin locus [38] have revealed that the hypersensitive site 2
HS2) enhancer is transcribed into a lncRNA. Subsequently, several
GS-based studies have revealed widespread transcription from
nhancers, resulting in a class of lncRNAs termed enhancer RNAs
eRNAs).
Using chromatin immunoprecipitation with sequencing (ChIP-
eq) to map  genomic binding sites of the enhancer protein CBP, Kim
t al. [39] identiﬁed over 12,000 stimulus-dependent enhancers in
ouse neurons. Furthermore, ChIP-seq showed Pol II to be present
t over 25% of those enhancers. RNA-seq of total RNA from neurons
as revealed lncRNAs that are produced in both directions from
uch Pol II-bound enhancers, and the expression levels of these
RNAs are correlated with mRNA synthesis from nearby genes [39].
In a related study, De Santa et al. [40] have applied ChIP-seq of
ol II in macrophages to reveal actively elongating Pol II bound to
utative enhancer sites upstream of lipopolysaccharide-inducible
enes. Many of these Pol II-bound enhancers are actively tran-
cribed, and eRNA expression correlates with the expression of
eighbouring genes. Notably, eRNA synthesis frequently precedes
he induction of the adjacent coding gene [40]. Furthermore, a
eta-analysis of RNA-seq data has shown that enhancer function
ssociated with production of lncRNAs from mammalian ultra-
onserved elements is much more widespread than previously
hought [41].
Such NGS studies have raised the possibility that enhancer func-
ion may  in fact be mediated through transcribed eRNAs. While itopmental Biology 23 (2012) 200– 205
has been speculated that eRNAs may  recruit enhancer-associated
proteins, or perhaps facilitate chromatin looping to provide contact
between the enhancer region and the promoter of the regulated
gene, further studies are required to determine any biological func-
tions and mechanisms of action of eRNAs (reviewed in [42]).
2.4. Long intergenic ncRNAs (lincRNAs)
In mammals, large projects such as those of the FANTOM and
ENCODE consortiums [5,9] have uncovered widespread intergenic
transcription which does not overlap with protein-coding genes.
Guttman et al. [15] have developed a method to systematically
identify such long intergenic ncRNAs (lincRNAs) using genome-
wide chromatin-state maps, generated by ChIP-seq, to identify
discrete transcriptional units occurring between protein-coding
genes. Based on the observation that Pol II-transcribed genes dis-
play H3K4Me3 marks at their promoters and H3K36Me3 marks
along their bodies, ‘K4–K36’ domains lying outside of known
protein-coding genes were uncovered. This approach identiﬁed
1600 lincRNAs in four mouse cell types.
More recently, a comprehensive annotation of human lincR-
NAs has been achieved using transcriptome assembly of RNA-seq
data from 24 human tissues and cell types [13]. ‘Align-then-
assemble’ ab initio transcriptome assembly should theoretically
be more sensitive than ‘assemble-then-align’ de novo approaches
which are biased towards highly expressed transcripts, although
a comprehensive comparison has yet to be made [43]. By select-
ing from the RNA-seq reconstructions those lincRNAs that are
reliably expressed, a stringent set of 4662 lincRNAs has been pro-
duced [13]. Importantly, the authors have found that the identiﬁed
lincRNAs are expressed in a highly tissue-speciﬁc manner, much
more so than protein-coding genes. In addition, protein-coding
genes proximal to lincRNAs are disproportionately associated with
development and transcriptional regulation [14,15,29],  hinting at
possible functional roles of lincRNAs.
One of the most well-characterised lincRNAs is HOTAIR, which
is transcribed within the HOXC cluster and represses genes in the
HOXD cluster by binding and recruiting the chromatin-modifying
complex PRC2 [44]. Khalil et al. [45] show that many lincRNAs
are bound by PRC2 and other chromatin-modifying complexes.
Moreover, RNAi-based depletion of various PRC2-associated lincR-
NAs results in activation of genes known to be repressed by PRC2
[45]. Such studies have led to the suggestion that lincRNAs guide
chromatin-modifying complexes to speciﬁc genomic loci (reviewed
in [46]).
2.5. Repetitive element-associated ncRNAs
Repetitive elements such as retrotransposons comprise 30–50%
of mammalian genomes, and the advent of NGS technologies
has uncovered transcriptional activity associated with such ele-
ments. Cross-hybridisation problems have hampered the use of
array-based approaches to study genome-wide repetitive element
transcription. In contrast, sequence-tag technologies can detect
single base-pair differences between repetitive elements, enabling
their discrimination.
Using a ‘deep-CAGE’ method to globally map  transcription start
sites (cleavage of ∼20-nucleotide tags from extreme 5′ and 3′
ends of cDNAs, followed by sequencing), the FANTOM4 project has
revealed extensive transcription of retrotransposons in human and
mouse genomes [36]. Retrotransposons are expressed in a tissue-
speciﬁc manner and proximal to protein-coding genes, suggesting
roles of controlling alternative promoters or post-transcriptionally
regulating protein-coding transcripts (reviewed in [47]).
Pseudogenes form another class of repetitive elements that can
be transcribed into lncRNAs, as has recently been shown for the
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TEN and KRAS loci, which can regulate expression of their corre-
ponding protein-coding genes by competing for regulatory miRNA
inding [48,49].
. Post-transcriptional processing of lncRNAs
Understanding the molecular pathways governing the produc-
ion, function, and turnover of lncRNA is key to understanding their
iversity and functions. For instance, the transcriptomes of budding
east rrp6 mutants – defective for the nuclear exosome complex
nvolved in RNA degradation – have revealed a class of transcripts
eferred to as CUTs, which are rapidly degraded after synthesis
see Section 2.2) [22,32].  There is evidence that physiological con-
itions may  affect the unstable nature of CUTs and render them
table. For example, loss of the Rrp6 protein in budding yeast leads
o stabilisation of an AS transcript to the PHO84 gene, and sub-
equent repression of PHO84 transcription. Intriguingly, the same
henotype is observed during chronological aging, as the Rrp6 pro-
ein shows weaker association with the PHO84 locus under these
onditions [50]. In addition, a class of meiotic ncRNA is actively
egraded during the mitotic cell-cycle by the nuclear exosome and
ecomes stabilised as the cell proceeds into meiotic differentia-
ion [51]. These ﬁndings indicate that modulation of Rrp6 function
y external, physiologically relevant cues could contribute to gene
egulation, and that unstable transcripts could represent regulatory
lasses of lncRNAs.
Strand-speciﬁc RNA-seq of an xrn1 exonuclease mutant
as identiﬁed 1658 Xrn1p-sensitive unstable transcripts (XUTs)
egraded by the 5′–3′ cytoplasmic RNA decay pathway in budding
east [52]. More than 50% of the identiﬁed XUTs are AS transcripts,
nd they accumulate in lithium-containing media indicating a pos-
ible role in adaptive responses to changing growth conditions.
Native elongating transcript sequencing (NET-seq) – the deep
equencing of the 3′ ends of nascent transcripts associated with Pol
I – follows RNAs as they are produced, regardless of their stabil-
ty, making it ideally suited to analyze unstable transcripts. This
echnique has recently been used to proﬁle nascent transcripts
n budding yeast defective for the Rpd3S deacetylation complex,
evealing a pervasive increase in unstable AS transcription pro-
uced from bidirectional promoters [53]. This study suggests that
pd3S deacetylation enforces strong directionality to most promot-
rs, suppressing bidirectional transcription under normal growth
onditions. Similarly, it has also been shown in ﬁssion yeast that
he variant histone H2A.Z, which localises at 5′ ends of genes,
ooperates with heterochromatin and RNA interference factors to
uppress AS transcription under normal growth conditions [27].
inally, another study in yeast suggests an unexpected role of the
rd1–Nab3–Sen1 complex in termination of ncRNA processing,
howing its association not only with snoRNAs and CUTs but also
ith a class of AS transcripts [54].
Such transcriptomic studies demonstrate that lncRNAs are
ctively regulated transcriptionally and post-transcriptionally and
llustrate that systematic RNA-seq analysis of mutants defective for
hromatin maintenance or RNA processing pathways is a powerful
pproach to reveal novel, possibly regulatory, classes of lncRNAs.
. Functional sites and expression regulation of lncRNAs
To determine biological roles of lncRNAs, it is important to
stablish the conditions and cell types they are expressed in
nd the subcellular locations where they function. Speciﬁc and
ynamic expression patterns, are emerging for several lncRNAs,
hich intrinsically suggest functionality ([55], reviewed in [10]).lopmental Biology 23 (2012) 200– 205 203
4.1. Subcellular locations of lncRNAs
A study in human cell lines suggests that ∼30% of lncRNAs are
found exclusively in the nucleus, ∼15% are found exclusively in the
cytoplasm, while ∼50% show both nuclear and cytoplasmic locali-
sation [56]. Such a subcellular distribution implicates lncRNAs in
gene regulation at both transcriptional and post-transcriptional
levels. Indeed, these are two functional themes emerging from
recent reports based on the analysis of individual lncRNAs.
At a transcriptional level, lncRNAs emerging from promoters or
enhancers may  act as scaffolds by binding, recruiting, or coordinat-
ing transcriptional activators and repressors [17,18]. Additionally,
it has been suggested that the process of lncRNA transcription,
rather than the lncRNA product itself, may  be functional by facil-
itating an open chromatin structure at protein-coding promoters,
thereby increasing access to transcriptional activators and to Pol II
[57].
At a post-transcriptional level, the ability of lncRNAs to
recognise complementary sequences may  enable highly speciﬁc
regulatory interactions with mRNAs. This provides opportunities
for lncRNAs, in particular AS transcripts, to regulate the splicing,
editing, transport, translation, or degradation of mRNAs.
Examples of different modes of action of lncRNAs in tran-
scriptional or post-transcriptional gene regulation have been
extensively reviewed elsewhere [17,18]. RNA-seq proﬁling of dif-
ferent cellular fractions will help to obtain a global view of lncRNAs
potentially acting at transcriptional and/or post-transcriptional
levels.
Two recent studies have employed ribosomal proﬁling – the
deep sequencing of ribosome-protected RNAs – to determine
whether any lncRNAs are found in association with ribosomes
[58,59]. A key step in the annotation of lncRNAs is demonstrat-
ing the absence of a conventional open reading frame. Remarkably,
however, these studies have revealed that over half of the anno-
tated SUTs in budding yeast [58] and the majority of annotated
lincRNAs in mouse embryonic stem cells [59] are exported to
the cytoplasm, where they are engaged by the protein translation
machinery. The extent to which lncRNAs, such as SUTs and lincR-
NAs, might act via proteins they encode rather than via RNA itself,
is now an open question. It has been suggested that the low-level
translation of some lncRNA transcripts may help provide the raw
material for de novo birth of protein-coding genes [58].
Furthermore, deep-sequencing of the human mitochondrial
transcriptome has revealed the presence of mitochondrial lncRNAs
[60]. It will be of interest to determine whether such lncRNAs play
any mitochondrial-speciﬁc roles.
4.2. Chromatin-related functions
As described above, an additional emerging theme of lncRNA
function is in guiding chromatin-modifying complexes to speciﬁc
genomic loci. Such a function helps to solve the apparent paradox of
how chromatin-remodelling complexes with little DNA  sequence
speciﬁcity, but often with RNA-binding domains, are able to control
complex chromatin modiﬁcations at speciﬁc genomic loci.
Many lncRNAs whose mechanism of action are well-
characterised, such as HOTAIR [44] and Xist (reviewed in [61]),
use chromatin as a substrate to execute their biological function.
It has therefore been postulated that lncRNAs associated with
chromatin may  be more likely to have biological functions. By
sequencing the RNAs of chromatin fractions, approximately 200
such chromatin-associated ncRNAs (CARs) have been detected in
human ﬁbroblast cells, implicating them in possible structural and
functional roles in chromatin organisation [62].
To further probe the function of such CARs, it will be nec-
essary to determine exactly where they bind to chromatin.
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 recently described technique, Chromatin Isolation by RNA
uriﬁcation(ChIRP)-seq, could enable such analyses on a genome-
ide scale [63]. Chromatin is cross-linked to lncRNAs, and
iotinylated oligonucelotide probes are then used to retrieve spe-
iﬁc lncRNAs, together with bound DNA sequences which can then
e interrogated by NGS. Just as ChIP-seq has greatly improved our
nderstanding of protein–DNA interactions on a genomic scale,
hIRP-seq has the potential to map  lncRNA:chromatin interactions
n vivo, genome-wide and at high resolution. ChIRP-seq has been
pplied to three lncRNAs – TERC, HOTAIR and roX2 – revealing that
ncRNA binding sites resemble transcription factor binding sites in
eing focal, numerous and sequence-speciﬁc [63].
.3. Speciﬁc and dynamic expression of lncRNAs
In addition to determining where in the genome lncRNAs orig-
nate and where in the cell they function, determining under what
onditions and in what cells they are expressed can provide key
nsights into their function. Initial studies in mouse and human
ave demonstrated that many lncRNAs are expressed in a cell-
nd tissue-speciﬁc manner during development and differentia-
ion, suggesting that they might participate in the regulation of
uch processes ([64], reviewed in [65]).
RNA-seq is ideally suited to quantify transcripts, and expres-
ion levels can be easily compared across different conditions and
issues, without the need for complicated normalisation methods
reviewed in [2]). A recent RNA-seq study [13] has demonstrated
hat the vast majority of lincRNAs show tissue-speciﬁc expression
atterns, with as much as 78% being categorised as tissue-speciﬁc
ompared to only ∼19% of the coding genes. Notably, a large group
f lincRNAs are speciﬁc to testes [13]. Another RNA-seq study
66] has analyzed the transcriptomes of 102 prostate cancer sam-
les, deﬁning 121 lncRNAs whose expression patterns distinguish
wo stages of cancer development. One such lncRNA is a prostate-
peciﬁc regulator of cell proliferation [66]. Similar RNA-seq studies
f dynamic lncRNA expression across different conditions and
evelopmental stages in health and disease will provide compre-
ensive, sensitive and high-resolution data of lncRNA expression
egulation.
. Conclusions and outlook
RNA-seq is a powerful tool for the detection and quantiﬁca-
ion of lncRNAs. Several ongoing developments promise further
dvances in the insights that RNA-seq will be able to provide.
or instance, it is increasingly appreciated that gene expression in
ndividual cells deviates signiﬁcantly from the average behaviour
f cell populations [67]. Single-cell transcriptome proﬁling could
evolutionise our understanding of genome regulation beyond pop-
lation averages. Additionally, single-cell RNA-seq would enable
ranscriptome studies where only tiny amounts of cellular mate-
ial are available, such as during early embryonic development
r disease-associated samples. By exploiting microﬂuidics systems
or single-cell delivery, technologies for single-cell transcriptome
roﬁling are already emerging (reviewed in [3]).
Biases and artifacts in RNA-seq data are frequently introduced
uring cDNA synthesis and the subsequent manipulation steps
n RNA library preparation. Direct high-throughput sequencing of
NA molecules, without prior cDNA conversion, offers the potential
o mitigate many of the current problems and biases. Direct RNA
equencing technologies are already on the horizon [68].Advances in algorithms used to analyse sequence data will
lso increase the power of RNA-seq to unravel transcriptomes.
or example, methods which enable transcriptome reconstruc-
ion in the absence of a reference genome will help to reveal
[opmental Biology 23 (2012) 200– 205
transcriptomic complexities in incompletely sequenced genomes,
as well as uncovering the full complexity for those with known
genome sequences. Such methods will also prove useful for cells
with highly rearranged genomes such as cancer cells (reviewed in
[43,69]).
A number of genome-wide association (GWA) studies have
shown that variations associated with complex disorders often map
to non-coding regions of the genome, implicating lncRNAs in dis-
ease (reviewed in [70]). While the mechanisms by which lncRNAs
may  contribute to pathogenesis are largely unknown, several lncR-
NAs have already been suggested to play a role in various diseases,
through alterations in their expression levels or interactions with
RNA-binding proteins [13]. A recently described technique, termed
RNA CaptureSeq, employs tiling arrays of targeted genomic regions
to capture cDNAs, followed by deep sequencing [71]. For targeted
loci, such an approach enables a greater depth of coverage than can
be achieved by conventional RNA-seq, and has revealed additional
complexities in the human transcriptome. By enabling compre-
hensive interrogation of speciﬁc genomic regions, RNA CaptureSeq
could be used to proﬁle all transcripts produced from non-coding
regions implicated in disease-susceptibility by GWA  studies.
Being potentially more amenable drug targets than proteins,
lncRNAs present a new frontier in biomedicine. No doubt, RNA-
seq and other NGS-based approaches will continue to advance our
understanding of the nature, extent and possible functions of lncR-
NAs in health and disease.
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